Bicycle Therapeutics PLC Sponsored ADR BCYC
3.69
(0.04)
(1.07%)
as of 25 Sep
- Market cap
- $199.4M
- P/E
- 0.0×
Follow BCYC
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
6.76 | 23.10 | 24.33 | 61.52 | 130.42 | 33.08 | 7.55 | 0.93 | 0.93 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(25.35) | (86.73) | (13.88) | (29.36) | (146.19) | (20.68) | (21.17) | (1.92) | (1.92) | — |
P/B ratio |
0.80 | 1.03 | 1.77 | 3.29 | 4.41 | 3.60 | 1.12 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.80 | 1.03 | 1.77 | 3.29 | 4.41 | 3.60 | 1.12 | 0.00 | 0.00 | — |
EV/Sales |
(1.61) | (1.30) | 6.13 | 40.39 | 95.67 | 21.47 | 1.01 | (4.61) | (4.61) | — |
EV/EBITDA |
0.48 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.31 | 2.31 | — |
EV/Operating CF |
0.47 | 0.28 | (2.73) | (6.78) | (75.65) | (12.54) | (0.49) | 2.06 | 2.06 | — |
EV/FCF |
0.46 | 0.28 | (2.60) | (5.56) | (66.52) | (11.75) | (0.46) | 1.95 | 1.95 | — |
Quick Ratio |
11.65 | 13.61 | 7.92 | 6.76 | 12.43 | 6.51 | 11.25 | 8.37 | 7.48 | 2.83 |
Current Ratio |
11.98 | 13.81 | 8.08 | 6.92 | 12.65 | 6.73 | 11.81 | 8.60 | 7.57 | 2.96 |
Net Debt/EBITDA |
2.61 | 4.34 | 2.70 | 2.73 | 6.37 | 2.40 | 3.59 | 3.01 | 4.26 | 0.71 |
Debt/Assets |
0.00% | 0.00% | 5.16% | 7.38% | 6.23% | 9.00% | 1.14% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.08 | 0.11 | 0.09 | 0.15 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.09 | 0.05 | 0.05 | 0.03 | 0.04 | 0.08 | 0.14 | 0.09 | 0.05 | 0.00 |
Operating CF/Net income |
1.14 | 0.97 | 0.34 | 0.76 | 0.22 | 0.35 | 0.93 | 1.19 | 0.09 | 0.83 |
Capex/Depreciation |
(0.37) | (0.17) | (0.45) | (5.15) | (1.44) | (0.94) | (1.62) | (1.67) | (3.35) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (31.21%) | (29.04%) | (56.31%) | (36.53%) | (30.25%) | (54.08%) | (261.92%) | 37.34% | 40.16% | 33.37% | |
| (26.15%) | (21.78%) | (35.92%) | (25.32%) | (20.85%) | (37.60%) | (31.91%) | (28.07%) | (37.88%) | (31.48%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (704.84%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(34.65%) | (19.41%) | (35.64%) | (33.63%) | (15.71%) | (37.81%) | (31.36%) | (31.36%) | (25.64%) | (169.01%) |
Average Days of Receivables |
178.99 | 368.91 | 325.26 | 535.20 | 371.65 | 514.06 | 188.97 | 578.65 | 531.73 | 0.00 |
Research and Development Expense of Revenue |
331.03% | 490.34% | 580.13% | 564.26% | 383.69% | 319.05% | 185.06% | 290.93% | 576.02% | 0.00% |
Selling, General and Administrative Expense of Revenue |
109.34% | 204.62% | 224.00% | 342.30% | 277.29% | 281.05% | 105.50% | 113.80% | 311.02% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
54.37% | 107.95% | 120.39% | 185.16% | 103.30% | 62.69% | 22.34% | 14.34% | 25.00% | — |
Graham Net Nets |
1.17 | 0.94 | 0.51 | 0.26 | 0.21 | 0.26 | 0.84 | (8.28) | (8.28) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 422.12 | 0.00 | — |
Earnings Yield |
(44.63%) | (20.57%) | (27.82%) | (12.67%) | (4.42%) | (14.76%) | (105.80%) | (426.67%) | (426.67%) | — |
Free Cash Flow Yield |
(51.38%) | (20.37%) | (9.68%) | (11.81%) | (1.10%) | (5.53%) | (28.96%) | (253.26%) | (253.26%) | — |
Revenue per Share |
1.05 | 0.61 | 0.76 | 0.49 | 0.47 | 0.54 | 1.25 | 16.26 | 6.18 | 0.00 |
Operating CF per Share |
(3.60) | (2.83) | (1.70) | (2.90) | (0.59) | (0.93) | (2.59) | (59.42) | (4.25) | (0.54) |
Capex per Share |
(0.03) | (0.02) | (0.08) | (0.64) | (0.08) | (0.06) | (0.14) | (2.70) | (3.34) | 0.00 |
Free Cash Flow per Share |
(3.64) | (2.85) | (1.79) | (3.54) | (0.67) | (0.99) | (2.73) | (62.12) | (7.59) | (0.54) |
Cash per Share |
9.07 | 15.11 | 14.79 | 11.43 | 17.50 | 7.10 | 8.34 | 144.41 | 203.13 | 0.45 |
Shareholders Equity per Share |
8.80 | 13.62 | 10.42 | 9.13 | 13.82 | 4.99 | 8.44 | (159.09) | (141.65) | 0.38 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.80 | 13.62 | 10.42 | 9.13 | 13.82 | 4.99 | 8.44 | (159.09) | (141.65) | 0.38 |
Free Cash Flow |
(252.02) | (165.96) | (63.56) | (105.10) | (16.82) | (18.99) | (30.17) | (27.26) | (2.53) | (11.27) |
Working Capital |
625.90 | 861.38 | 492.33 | 316.04 | 422.32 | 132.59 | 95.33 | 67.84 | 62.06 | 7.48 |
Capital Expenditures |
(2.35) | (1.23) | (2.93) | (18.99) | (2.03) | (1.20) | (1.55) | (1.19) | (1.11) | (0.24) |
Net Current Asset Value |
575.27 | 764.80 | 337.46 | 229.56 | 325.02 | 90.03 | 87.15 | (74.68) | (49.67) | 7.48 |
EV/EBIT |
0.47 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.23 | 2.23 | — |
Capex to Sales |
0.03 | 0.04 | 0.11 | 1.31 | 0.17 | 0.12 | 0.11 | 0.17 | 0.54 | — |
Net Profit Margin |
(301.66%) | (479.18%) | (669.72%) | (779.35%) | (571.25%) | (490.95%) | (221.78%) | (306.14%) | (789.27%) | 0.00% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.07 | 0.75 | 0.45 | 0.19 | 0.45 | 0.55 | 0.42 | 0.39 | 0.24 | 0.52 |
Cash ROIC |
(20.65%) | (10.42%) | (8.10%) | (16.43%) | (2.20%) | (8.17%) | (16.57%) | 432.76% | (13.56%) | (67.64%) |
Accounts Receivable Turnover |
2.04 | 1.18 | 1.19 | 0.87 | 0.88 | 0.95 | 1.50 | 1.00 | 0.94 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,553.51 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | — | 0.00 |
Average Receivables |
35.62 | 29.85 | 22.62 | 16.56 | 13.27 | 10.89 | 9.23 | 7.16 | 2.19 | 2.19 |
Average Payables |
12.73 | 14.42 | 9.76 | 4.60 | 2.04 | 1.66 | 1.92 | 1.98 | 1.97 | 1.97 |
Average Assets |
837.23 | 776.11 | 502.98 | 445.20 | 320.47 | 135.67 | 95.91 | 77.81 | 42.92 | 42.92 |
Average Common Equity |
701.52 | 582.00 | 320.86 | 308.52 | 220.86 | 94.33 | 11.69 | (58.50) | (40.49) | (40.49) |
Columns are period end dates